KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Tax Rate (2016 - 2025)

Pfizer (PFE) has disclosed Tax Rate for 17 consecutive years, with 0.12% as the latest value for Q4 2025.

  • On a quarterly basis, Tax Rate fell 420988.0% to 0.12% in Q4 2025 year-over-year; TTM through Dec 2025 was 2.0%, a 165.0% decrease, with the full-year FY2025 number at 3.54%, down 319.0% from a year prior.
  • Tax Rate was 0.12% for Q4 2025 at Pfizer, up from 2.38% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 4210.0% in Q4 2024 to a low of 6.79% in Q1 2025.
  • A 5-year average of 248.05% and a median of 9.98% in 2024 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: surged 419075bps in 2024, then crashed -420988bps in 2025.
  • Pfizer's Tax Rate stood at 1.6% in 2021, then skyrocketed by 347bps to 3.96% in 2022, then skyrocketed by 387bps to 19.25% in 2023, then soared by 21766bps to 4210.0% in 2024, then tumbled by -100bps to 0.12% in 2025.
  • Per Business Quant, the three most recent readings for PFE's Tax Rate are 0.12% (Q4 2025), 2.38% (Q3 2025), and 4.63% (Q2 2025).